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Abstract
Low energy and protein intakes have been associated with an increased risk of malnutrition in outpatients with chronic obstructive pulmonary
disease (COPD). We aimed to assess the energy and protein intakes of hospitalised COPD patients according to nutritional risk status and
requirements, and the relative contribution from meals, snacks, drinks and oral nutritional supplements (ONS), and to examine whether either
energy or protein intake predicts outcomes. Subjects were COPD patients (n 99) admitted to Landspitali University Hospital in 1 year (March
2015–March 2016). Patients were screened for nutritional risk using a validated screening tool, and energy and protein intake for 3d, 1–5d after
admission to the hospital, was estimated using a validated plate diagram sheet. The percentage of patients reaching energy and protein intake
≥75% of requirements was on average 59 and 37%, respectively. Malnourished patients consumed less at mealtimes and more from ONS than
lower-risk patients, resulting in no difference in total energy and protein intakes between groups. No clear associations between energy or protein
intake and outcomes were found, although the association between energy intake, as percentage of requirement, and mortality at 12 months of
follow-up was of borderline signiﬁcance (OR 0·12; 95% CI 0·01, 1·15; P= 0·066). Energy and protein intakes during hospitalisation in the study
population failed to meet requirements. Further studies are needed on how to increase energy and protein intakes during hospitalisation and after
discharge and to assess whether higher intake in relation to requirement of hospitalised COPD patients results in better outcomes.
Key words: Malnutrition: Chronic obstructive pulmonary disease: Mortality: Readmission: Length of stay
Malnutrition is a frequently observed problem in patients with
chronic obstructive pulmonary disease (COPD) with an
estimated prevalence of 20–45%, depending on the criteria
used to assess(1–4). Malnutrition in patients with COPD is
associated with higher mortality(5,6), even after adjusting for
possible confounders such as forced expiratory volume in 1 s
(FEV1)
(6) and length of hospital stay (LOS) is almost twice the
duration in those who are malnourished compared to those
who are at low nutritional risk(5).
In general, low energy and protein intakes can be a cause of
malnutrition in patients(7), and decreased food intake among
hospitalised patients has been observed in many studies in
different patient groups(8–12). Few studies have examined energy
and protein intakes in hospitalised COPD patients(13–16) and none
have demonstrated whether there is a difference in intake
associated with nutritional risk status or body composition.
Vermeeren et al.(13) reported an energy intake of 4469
(SD 2293) kJ (1068 (SD 548) kcal) at day 1 of hospitalisation, which
increased substantially to 9050 (SD 2489) kJ (2163 (SD 595) kcal) at
day 4 and remained stable until discharge in COPD patients
hospitalised with an acute exacerbation (35% had BMI
≤ 21kg/m2). A study by Sundwall et al.(14) showed that despite
enrichment of the hospital meals and use of oral nutritional
supplements (ONS), which is recommended for patients at
Abbreviations: COPD, chronic obstructive pulmonary disease; FFMI, fat-free mass index; LOS, length of hospital stay; ONS, oral nutritional supplements; REE,
resting energy expenditure.
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nutritional risk, the average energy intake on a group level during
the whole hospital stay was lower than recommended in patients
with severe COPD (57% had BMI< 22kg/m2 and 53% of the
females and 76% of the males had low fat-free mass index
(FFMI)). In a study by Vermeeren et al.(15), reduction in habitual
intake before admission was reported by 51% of the nutritionally
depleted hospitalised COPD patients, the majority of whom had
severe or very severe disease (mean energy intake decreased
from 9523 (SD 2636) to 6067 (SD 2247) kJ/d (2276 (SD 630) to 1450
(SD 537) kcal/d)).
Although many hospitalised patients in different populations
do not reach the recommended energy or protein intakes, it
seems that achieving ≥75% of energy and protein requirements
is critical(17). A decreased risk of complications, shorter LOS and
better body weight maintenance have been reported in general
hospitalised patients at nutritional risk achieving ≥75% of their
energy and protein requirements(12,17,18), but studies that
examine intake in both nutritionally adequate COPD patients
and those at nutritional risk are lacking. Furthermore, informa-
tion on the associations between dietary intake and disease-
related variables other than malnutrition are rare in COPD
patients. To our knowledge, only one study has previously
examined the correlation between energy and protein intakes
and disease severity in hospitalised patients with COPD(19), and
none has examined the association with prospective outcomes
– for example LOS, readmission within 30 d or mortality. Low
food and nutrient intake in general and in relation to require-
ment has been linked to increased mortality in a mixed group of
hospitalised patients; however, only few of them had COPD
(5–7%)(8,9,12). Thus, the aims of this study were: (1) to assess
the overall energy and protein intakes of hospitalised patients
with COPD according to nutritional risk status and require-
ments, and the relative contribution from meals, snacks, drinks
and ONS; (2) to determine the number of patients achieving
≥75% of their predicted energy and protein requirements; and
(3) to examine whether low energy and protein intakes in
relation to requirements predicts LOS, hospital readmissions
within 30 d and mortality in hospitalised patients with COPD.
Methods
Subjects
In this observational study, data were used in a cross-sectional
and a longitudinal manner. Patients with COPD admitted to the
Department of Pulmonary Medicine at the Landspitali National
University Hospital were recruited from March 2015 until March
2016 (n 236) mostly owing to acute exacerbation. Patients able
to eat and drink orally, who were judged to be able to maintain
their balance on a device to measure body composition and who
had an anticipated length of hospitalisation of >3 d (evaluated by
medical staff in the department) were invited to participate.
Those who were not able to eat orally judged by Speech
Pathologist and patients with cognitive impairment assessed with
Mini-Mental Status Examination (MMSE)(20) were excluded.
The study was approved by the hospital’s Bioethics Com-
mittee (reference no. 12/2015) and by the medical directorate of
the hospital (16, LSH 28–15). All patients provided written
informed consent before their inclusion in the study. According
to the hospital protocol, if patients were at nutritional risk
according to screening (score≥ 4) (see below), individualised
nutritional support was offered, for example, energy- and
protein-dense food and/or ONS and/or dietary advice(21).
Standard food provision by the hospital kitchen to all patients
consists of ﬁve meals daily, providing about 8368 kJ (2000 kcal)
and 90 g (18%E) of protein daily. All types of additional food
are allowed to be brought to the hospital by the patient and/or
friends and relatives.
Sample size considerations
A priori sample size calculations indicated that a sample size of
36/group would be sufﬁcient to detect a difference of 837 kJ
(200 kcal) in energy intake as signiﬁcant between well-
nourished and malnourished patients assuming a SD of 1255 kJ
(300 kcal) (with a given statistical power of 80% and a two-
sided signiﬁcance level of 5%). It has been shown that 837 kJ
(200 kcal) is a clinically meaningful amount of energy that has
been shown to improve anthropometric measures and grip
strength in COPD patients(22). Expecting a somewhat lower
percentage of the participants to be malnourished than well
nourished, the originally planned sample size was 100.
A post hoc power analysis was performed with our total
sample size of 99 and results from non-adjusted logistic
regression analyses, achieving a power of 49% for LOS≥ 7 d,
70% for readmission within 30 d and 81% for mortality.
Energy and protein intake
Total energy and protein intakes from the ﬁve meals provided by
the hospital kitchen were estimated using a validated plate dia-
gram sheet(23,24) for 3 d from 1 to 5 d after hospital admission,
starting on the 1st day of participation in the study. After each
meal, the proportion of the meal consumed by the subjects (0,
25, 50 or 100%) was recorded by a trained researcher or trained
hospital staff(23,24). The plate diagram sheet has special guidelines
on how to record each meal (online Supplementary Appendix
S1). Other snacks such as sweets, biscuits and yogurt and bev-
erages such as coffee, soft drinks and milk consumed were also
recorded, as well as intake from ONS. Total energy and protein
intake per actual body weight per d was calculated.
Energy and protein content from hospital food and from food
brought from home were analysed using Aivo2000 for Win-
dows, version 1.12.0.1 (2012; AIVO, AB). Nutrition data in the
programme is based on the Icelandic nutrient composition
database (ISGEM). Nutritional content of ONS was obtained
from the package label. To determine waste (in kJ (kcal) and g),
the total amount eaten was deducted from the total amount
provided to each patient.
Energy and protein requirements
Energy and protein requirements were estimated according to
the lower limit recommended by the Icelandic clinical guide-
lines for hospitalised patients (energy 105 kJ (25 kcal)/kg per d
and protein 1·2 g/kg per d)(21). The equation is simple and
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frequently used in the clinical setting as it only requires body
weight (not physical activity level or stress factor). It estimates
total energy expenditure, which is close to the resting
energy expenditure (REE) in hospitalised patients(21). Adjust-
ments were made before calculations if a patient’s BMI was
<18·5 kg/m2 (a factor for weight gain) and >27 kg/m2 – that is
weight included that corresponds to a BMI of 18·5 and 27 kg/m2
instead of actual weight.
Nutritional risk screening
For each patient, nutrition screening was undertaken by a
trained researcher on admission. The screening tool used is
recommended by the clinical guidelines for hospital nutrition at
Landspitali(21) and has been validated against a full nutritional
assessment in COPD patients(3) (online Supplementary
Appendix S2) and predicts mortality in COPD patients(25).
Nutritional risk is categorised as low (score 0–1), medium
(score 2–3) and high (score≥ 4). A total score of ≥4 is con-
sidered ‘at high nutritional risk’. Following screening, patients
considered to be ‘at nutritional risk’ were categorised into those
who were malnourished and those who were not malnourished
using the criteria recently proposed by The European Society
for Clinical Nutrition and Metabolism (ESPEN)(7).
Body composition
Body composition was measured by a trained researcher in the
morning, after breakfast within 48h of study enrolment using a
portable, multi-frequency (20 kHz, 100 kHz) bioelectrical impe-
dance analysis (BIA) device (InBody230 Co., Ltd). The device
measures a patient’s weight (kg), estimates total body water (kg),
body fat mass (BFM; kg) and fat-free mass (kg). BMI (kg/m2) and
FFMI (kg FFM/m2) were calculated. Information on height was
collected from the electronic hospital patient records.
Classiﬁcation of disease severity
FEV1 and forced vital capacity (FVC) were measured by spirometry
(Jaeger MS-PFT®; CareFusion) and disease severity was classiﬁed
using the GOLD criteria(26). All measurements were carried out
by a trained researcher towards the end of the hospital stay.
Electronic medical records
Socio-demographic data, date of admission, readmission within
30 d, LOS and mortality at 1 year of follow-up were collected
from the electronic medical records from the hospital. LOS was
both used as a continuous variable and dichotomous variable –
for example, <7 d and ≥7 d – which is in agreement with policy
at the hospital aiming that LOS should not exceed 7 d.
Statistical analysis
Patients were stratiﬁed into four subgroups by nutritional status:
(1) not at nutritional risk, (2) at nutritional risk by screening,
(3) at nutritional risk by screening, but not malnourished
and (4) malnourished according to ESPEN diagnosis. The
Kolmogorov–Smirnov test was used to test normality of data.
Baseline characteristics were presented as medians and 95% CI.
Mann–Whitney U test was used to test differences between
continuous data and Pearson’s χ2 test was used for categorical
data. Logistic regression analyses were used to determine any
associations between energy and/or protein intake, as a
percentage of predicted requirements, and LOS≥ 7 d, 30-d
readmission and mortality in a 12-month follow-up. Results
were shown in different models with various degrees of statis-
tical correction: unadjusted (model 1), adjusted for nutritional
status (model 2) and nutritional status and sex (model 3)
because previous studies have shown association between
those variables and outcomes measured(25,27,28).
Statistical analysis was conducted using SPSS for Windows
version 24.0 (SPSS) and the level of signiﬁcance was set at
P< 0·05. G*Power Software for Windows version 3.1.9.2
(Heinrich-Heine-University Düsseldorf) was used to perform
post hoc power analyses for logistic regression analyses.
Results
Subjects
In total, 236 patients were screened for nutritional risk during the
study period. Of these, 29 (12%) refused to participate and
another 70 (30%) patients were not eligible, because of a pre-
dicted admission of <3d (19 (27%)), not being able to stand in
an upright position for 60 s (the time it takes to measure body
composition using BIA) or judged by the nursing staff to be too
sick to be able to participate (42 (60%)). Of those, six were not
able to eat orally, judged by a Speech Pathologist. Nine patients
(13%) were not eligible for other reasons – for example cogni-
tive impairment (MMSE <19). Of those seventy patients who
were not eligible, 25 (36%) were deﬁned as being at nutritional
risk when using the screening tool proposed by Landspitali
University hospital. A ﬂow chart of recruitment is shown in Fig. 1.
In total, 137 (58%) consented to participate in the study;
however, 38 (28%) had insufﬁcient data available – e.g. early
discharge and record of energy and protein intake discarded.
Thus, ninety-nine participants were included in the present
analyses (Table 1). All variables (except age, height and LOS)
were signiﬁcantly lower in malnourished patients (according to
ESPEN criteria) compared with those who were not at nutri-
tional risk by screening. Weight, BMI and BFM were also sig-
niﬁcantly lower in patients at nutritional risk by screening
compared with those who were not at risk.
Energy and protein intake
At Landspitali, routine food provision by the hospital kitchen to
all patients consists of ﬁve meals daily. Energy and protein
intakes for each of the ﬁve meals and overall intake from all
hospital food according to nutritional risk status are shown in
Table 2. Median intake of energy and protein from both lunch
and the evening meal and overall intake from hospital food was
signiﬁcantly lower in malnourished patients and those at nutri-
tional risk than those who were not at risk (P< 0·05). No sig-
niﬁcant difference was observed in energy and protein intakes
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from lunch and the evening meal, and overall intake from hos-
pital food, between those at nutritional risk by screening but not
malnourished and those who were not at risk. There were no
differences between groups in energy and protein intakes at
breakfast and afternoon and evening snack meals (Table 2).
The amount of food provided by the hospital kitchen did not
vary between groups of patients (Table 3). However, sig-
niﬁcantly more food was wasted by patients who were at
nutritional risk or malnourished compared with patients who
were not at nutritional risk as they tended to consume less
energy from the hospital food provided (Table 3).
When intake from additional food brought to hospital by the
patient and/or friends and relatives were considered with meals
and snacks provided by the hospital, and intake from ONS, there
was no signiﬁcant difference between groups in overall daily
energy and protein intakes. Patients at nutritional risk or
malnourished consumed signiﬁcantly more energy and protein
from ONS than those who were not at nutritional risk. The quantity
of additional food/snacks brought to hospital by the patient and/or
friends and relatives was in general very low, with no difference in
intake between groups (Table 3). According to our hospital pro-
tocol, appropriate dietary intervention is recommended to patients
at nutritional risk, such as providing energy- and protein-dense
hospital menu and ONS or in-between meals in addition to the
hospital menu. Only fourteen (36%) and twenty-two (56%) of
those patients received such intervention, respectively. However,
total energy and protein intake signiﬁcantly increased during
hospitalisation among subjects at nutritional risk (from median 5314
(95 % CI 4059, 6372) kJ/d (1270 (95 % CI 970, 1523) kcal/d) at the
1st day of food registration to 5858 (95 % CI 1117, 7167) kJ/d (1400
(95 % CI 267, 1713) kcal/d) on the last day, P=0·008, and 54·3g of
protein (95% CI 0·9, 65·6) to 59·4g of protein (95% CI 51·8, 71·3),
P=0·045) (online Supplementary Table S5).
Energy and protein requirements
Overall, total energy and protein intakes for all groups failed to
meet estimated requirements for energy and protein. Despite the
lower predicted energy and protein requirements in patients
diagnosed as malnourished using the ESPEN criteria, only 52%
malnourished patients reached an energy intake above 75% of
predicted requirements. The percentage of patients reaching
75% of their predicted protein needs was even lower than for
energy, ranging from 31 to 44% in the four groups presented in
Table 3. Energy requirements estimated using eight different
equations/methods resulted in overall requirements varying from
a median of 5264 (95 % CI 4971, 5356) to 8360 (95 % CI 8021,
8799) kJ (1258 (95% CI 1188, 1280) to 1998 (95% CI 1917, 2103)
kcal) in the whole group (online Supplementary Table S6).
Table 1. Patients’ characteristics at baseline
(Medians and 95% confidence intervals; numbers and percentages)
All (n 99) Not at risk (n 60)
Nutritional risk by
screening (n 39)
Nutritional risk by
screening, but not
malnourished (n 16)
Malnourished according
to ESPEN diagnosis
(n 23)
Median 95% CI Median 95% CI Median 95% CI Median 95% CI Median 95% CI
Age (years) 73·0 71·0, 77·0 72·0 69·0, 74·0 79·0* 71·0, 81·0 79·5* 69·0, 86·0 75·0 69·0, 81·0
Male/female
n 45/54 27/33 18/21 7/9 11/12
% 45/55 45/55 46/54 44/56 48/52
Height (cm) 169·0 167·0, 172·0 168·5 166·0, 174·0 170·0 163·0, 174·0 165·5 154·0, 180·0 172·0 163·0, 176·0
Weight (kg) 68·2 64·3, 77·1 82·1 73·0, 88·4 54·6* 49·0, 60·5 61·3* 51·0, 83·1 51·2* 45·8, 55·8
BMI (kg/m2) 24·8 22·7, 26·8 28·7 26·3, 31·3 19·1* 17·5, 20·7 22·7* 19·8, 25·8 17·4* 16·3, 18·2
Body fat mass (kg) 20·6 15·5, 24·9 29·4 24·9, 33·6 11·4* 8·0, 14·6 15·7* 8·0, 21·0 9·4* 6·6, 12·3
Fat-free mass (kg) 48·9 44·3, 52·1 52·2 45·3, 59·0 44·0* 36·8, 49·5 49·1 34·2, 61·5 39·8* 34·4, 47·7
Fat-free mass index (kg/m2) 16·9 16·1, 17·9 18·0 17·2, 19·5 14·8* 13·8, 16·2 17·5 14·1, 20·3 13·9* 13·1, 15·2
FEV1 (% predicted)† 40·0 35·0, 50·0 45·0 35·0, 56·0 37·0 31·0, 47·0 47·5 31·0, 75·0 36·0* 28·0, 41·0
Length of stay (d) 9·0 9·0, 11·0 9·0 8·0, 11·0 10·0 9·0, 13·0 10·5 8·0, 18·0 10·0 9·0, 13·0
ESPEN, European Society for Clinical Nutrition and Metabolism.
* Based on Mann–Whitney U test. Significantly different from patients not at risk according to screening (P<0·05).
† Not at risk: n 52; nutritional risk by screening: n 32; nutritional risk by screening, but not malnourished: n 14; malnourished according to ESPEN diagnosis: n 18.
Screened for nutritional risk
n 236
Refused to participate
n 29 (12 %)
No eligible n 70 (30 %)
Due to:
Too short admission n 19 (27 %)
Too sick or not able to measure
BIA n 42 (60 %)
Other reason n 9 (13 %)
Consented to participate
n 137 (58 %)
Insufficient data available
n 38 (16 %)
Included in the analyses
n 99 (42 %)
Fig. 1. Flow chart of recruitment. BIA, bioelectrical impedance analysis.
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Table 2. Average energy and protein intake early in hospital stay in each meal in patients categorised by (1) nutritional risk by screening and (2) diagnosis
of malnutrition using the European Society for Clinical Nutrition and Metabolism (ESPEN) criteria
(Medians and 95% confidence intervals)
Not at risk (n 60)
Nutritional risk by
screening (n 39)
Nutritional risk by screening, but
not malnourished (n 16)
Malnourished according to
ESPEN diagnosis (n 23)
Median 95% CI Median 95% CI Median 95% CI Median 95% CI
Energy (kJ/d)
Breakfast 1473 1326, 1753 1544 1301, 1753 1536 883, 1753 1544 1314, 1753
Lunch 2134 1933, 2343 1423* 1243, 2013 1527 1159, 2251 1356* 1238, 2092
Afternoon snack 837 724, 874 728 577, 874 728 452, 874 732 498, 933
Evening meal 1904 1741, 2054 1494* 1113, 1807 1648 1117, 2130 1406* 916, 1795
Evening snack 602 523, 632 561 397, 577 561 372, 682 548 205, 690
Overall intake from hospital food† 5803 4874, 6523 4853* 3812, 5418 5263 3799, 5966 4105* 3510, 5481
Protein (g/d)
Breakfast 9·7 8·7, 11·5 9·6 7·7, 11·1 9·6 5·8, 11·5 9·6 7·7, 11·5
Lunch 25·8 20·5, 28·6 19·1* 15·2, 24·8 21·2 13·6, 25·6 18·1* 15·0, 24·7
Afternoon snack 3·6 2·9, 3·7 3·3 2·6, 3·7 3·2 2·6, 3·9 3·3 2·1, 4·0
Evening meal 21·3 19·6, 25·8 17·3* 12·1, 22·6 18·8 10·4, 26·5 17·3* 11·3, 22·6
Evening snack 4·3 3·5, 5·8 4·2 2·9, 5·5 4·6 2·9, 7·6 4·2 0·8, 5·8
Overall intake from hospital food† 56·2 48·6, 58·8 45·8* 38·4, 53·8 53·8 38·4, 67·3 40·9* 36·0, 52·5
* Based on Mann–Whitney U test. Significantly different from patients not at risk according to screening (P<0·05).
† Median intake from overall intake from hospital food does not match with the sum calculation for each meal as some data for each meal are missing.
Table 3. Average energy and protein requirement, intake and plate waste in patients categorised by (1) nutritional risk by screening and (2) diagnosis of
malnutrition using the European Society for Clinical Nutrition and Metabolism (ESPEN) criteria
(Medians and 95% confidence intervals)
Not at risk (n 60)
Nutritional risk by
screening (n 39)
Nutritional risk by screening, but
not malnourished (n 16)
Malnourished according to
ESPEN diagnosis (n 23)
Median 95% CI Median 95% CI Median 95% CI Median 95% CI
Energy (kJ/d)
Meals served 7878 7766, 8008 7812 7498, 7962 7845 7284, 8104 7812 7456, 7937
Meals eaten 5803 4874, 6523 4853* 3812, 5418 5263 3799, 5966 4105* 3510, 5481
Waste 1799 1280, 2699 3088* 2063, 3548 2121 1310, 3515 3402* 2272, 4071
From extra ONS/drinks/snacks
ONS 0 0, 0 431* 0, 803 0* 0, 891 577* 176, 837
Drinks 176 71, 347 71 21, 293 46 13, 276 163 21, 364
Snacks 0 0, 0 0 0, 0 0 0, 0 0 0, 121
Total intake 6012 5117, 6694 5782 4125, 6268 5807 4117, 6648 5234 4071, 6268
Total intake (kJ/kg per d)† 71 63, 79 100* 79, 117 92* 63, 113 109* 79, 142
Requirement‡ 6870 6644, 7134 5711* 5125, 6330 6406 5335, 6853 5356* 4791, 5837
Intake/requirement§ 377 310, 397 347 272, 406 331 259, 406 356 268, 460
Reaching≥ 75% of requirement||
n 38 22 10 12
% 63 56 63 52
Protein (g/d)
Meals served 77·3 73·6, 79·1 77·2 74·0, 82·2 80·9 72·6, 83·4 75·8 71·2, 82·2
In meals served (%E) 16·6 16·0, 17·5 16·5 15·7, 17·3 17·2 15·4, 19·4 16·5 15·1, 17·4
Meals eaten 56·2 48·6, 58·8 45·8* 38·4, 53·8 53·8 38·4, 67·3 40·9* 36·0, 52·5
From meals eaten (%E) 17·1 15·8, 17·4 16·8 15·8, 17·5 17·1 14·9, 18·1 16·6 14·7, 17·8
Waste 15·1 11·3, 24·1 31·9* 19·8, 38·5 24·5 14·4, 39·4 36·1* 18·3, 40·6
From extra ONS/drinks/snacks
ONS 0·0 0·0, 0·0 4·0* 0·0, 8·0 0·0* 0·0, 10·8 6·0* 0·0, 8·0
Drinks 1·4 0·8, 2·2 0·7 0·4, 2·0 0·7 0·3, 2·0 0·7 0·4, 3·6
Snacks 0·0 0·0, 0·0 0·0 0·0, 0·0 0·0 0·0, 0·0 0·0 0·0, 0·3
Total intake 58·7 49·7, 62·0 54·2 41·4, 62·8 59·6 41·4, 67·5 51·2 40·7, 59·8
Total intake (g/kg per d)† 0·7 0·6, 0·8 1·0* 0·7, 1·2 0·9 0·6, 1·2 1·0* 0·7, 1·3
Requirement‡ 88·2 82·8, 92·5 68·9* 62·6, 74·3 73·5* 61·2, 91·4 65·5* 59·8, 70·3
Intake/requirement§ 63 60, 74 69 58, 81 67 54, 90 69 53, 84
Reaching≥ 75% of requirement||
n 21 15 5 10
% 35 39 31 44
ONS, oral nutritional supplements.
* Based on Mann–Whitney U test. Significantly different from patients not at risk according to screening (P<0·05).
† Values are based on intake per actual body weight.
‡ Calculations are based on lower value of estimated energy and protein requirement for other than intensive care unit patients (105 kJ/kg per d) and (1·2 g/kg per d) recommended
by Icelandic clinical guidelines(21). Adjustments were made before calculations if a patients’ BMI was <18·5 and >27 kg/m2.
§ Intake from the five meals served from the hospital kitchen (Extra ONS/drinks/snacks not included) as percentage of requirement.
|| Number of patients reaching≥75% of requirement from the five meals served from the hospital kitchen (extra ONS/drinks/snacks not included).
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Energy and protein intake health-related outcomes
Adjusted and non-adjusted logistic regression models were
used to investigate whether energy and/or protein intakes in
relation to requirement early in hospital stay were predictors of
adverse health outcomes. In total, seventy-ﬁve (76%) patients
had LOS≥ 7 d, twenty-one (21%) were re-admitted within 30 d
and twenty-two (22%) died within 12 months.
Associations between energy and protein intakes in relation
to requirement and outcomes in our study were not statistically
signiﬁcant (Table 4). However, there was a trend towards a
lower risk of 12-month mortality with higher energy intake in
relation to requirements (OR 0·12; 95% CI 0·01, 1·15; P= 0·066).
We observed similar results when we assessed whether
energy and protein intakes below 75% of energy and protein
requirements were predictors of adverse health outcomes.
FFMI was higher in patients with a higher intake of both energy
and protein. FFMI increased by 1·5kg/m2 for every additional
2092kJ (500kcal) and 1·2kg/m2 for every additional 20-g
intake of protein. Similar association was also seen for BMI
(y= 2·5kg/m2 per 2092kJ (500kcal), P= 0·009 and y= 2·26kg/m2
per 20 g, P= 0·005). No associations were seen between energy
and protein intakes and lung function (y= 3·5kg/m2 per 2092kJ
(500kcal), P= 0·273 and y= 2·3kg/m2 per 20 g, P= 0·426).
Discussion
Overall energy and protein intake from the ﬁve meals provided
by the hospital kitchen was signiﬁcantly lower in patients at
high nutritional risk or malnourished than patients who were
not at risk. However, total daily intake of energy and protein,
including snacks and ONS, was similar across all groups,
although all groups failed to meet their estimated requirements
for energy and protein. Patients at nutritional risk and those
who were malnourished consumed signiﬁcantly less energy
and protein from the two main meals provided, lunch and
dinner, despite being served similar amounts, but there was no
difference in intake between groups from breakfast and the
smaller ‘in-between meals’ (afternoon and evening snacks).
Our results suggest that malnourished patients have difﬁculty in
consuming large meals (lunch/dinner) but the additional con-
sumption of smaller energy-dense meals in similar amounts to
normally nourished patients is feasible. It has been shown that
smaller, energy-dense meals can increase energy and protein
intakes of hospitalised patients(29), and a more even distribution
of food provided throughout the day might lead to a higher total
energy intake in this group. Furthermore, as REE is often ele-
vated in weight-losing patients with COPD(29,30), providing
them with extra energy-dense meals might be beneﬁcial as it
could prevent further weight loss and promote weight gain,
which can reduce the risk of mortality(31).
It appears that, in the short term, patients at nutritional risk or
malnourished rely more on ONS than food to improve their
intakes than do normally nourished patients. It is not known,
however, whether this group of patients would maintain this
approach in the longer term or indeed whether it relates to the
practicalities of obtaining food during a hospital admission. In
the early phase of a COPD exacerbation, ONS might be more
effective at improving energy and protein intake, as liquids are
easier to consume and require less chewing in the presence of
nutrition impact symptoms such as shortness of breath and
early satiety, which increase the work of eating. There is a need
for studies looking at food fortiﬁcation of texture modiﬁed
meals in COPD patients that require less time and effort to
consume. In a systematic review by Hubbard et al.(32) in general
adult patients, no signiﬁcant differences in compliance with
ONS consumption were found between different settings – i.e.
hospital and community. However, there is considerably less
information on the compliance with in-between meal snacks
and food fortiﬁcation, both in hospital and after discharge.
According to our hospital protocol, appropriate dietary inter-
vention is recommended to patients at nutritional risk such as
providing energy- and protein-dense hospital menu and ONS or
in-between meals in addition to the hospital menu. However,
only fourteen (36%) and twenty-two (56%) of those patients in
our study received such intervention, respectively.
The energy intake of subjects in our study is considerably
lower than seen in many other studies in patients with
Table 4. Association between overall energy and protein intake from hospital food as a percentage of predicted requirements, and length of hospital stay
(≥7d), readmission within 30 d and mortality within 12 months (n 99)
(Odds ratios and 95% confidence intervals)
Model 1* Model 2† Model 3‡
OR 95% CI P OR 95% CI P OR 95% CI P
Length of stay ≥7 d
Energy intake/requirement§ 0·49 0·07 3·53 0·477 0·46 0·06 3·44 0·451 0·45 0·06 3·37 0·438
Protein intake/requirement§ 0·27 0·03 2·63 0·261 0·22 0·02 2·23 0·199 0·17 0·02 1·94 0·154
Readmission within 30 d
Energy intake/requirement§ 0·22 0·03 1·96 0·175 0·22 0·03 1·97 0·176 0·22 0·03 1·99 0·178
Protein intake/requirement§ 0·48 0·04 5·43 0·554 0·49 0·04 5·56 0·561 0·50 0·04 5·72 0·573
Mortality within 12 months
Energy intake/requirement§ 0·15 0·02 1·33 0·088 0·13 0·01 1·22 0·074 0·12 0·01 1·15 0·066
Protein intake/requirement§ 0·29 0·03 3·28 0·317 0·20 0·02 2·42 0·205 0·17 0·01 2·12 0·168
* Unadjusted.
† Adjusted for nutritional status.
‡ Adjusted for nutritional status and sex.
§ Calculations are based on lower value of estimated energy and protein requirement for other than intensive care unit patients (105 kJ/kg per d) and (1·2 g/kg per d) recommended
by Icelandic clinical guidelines(21). Adjustments were made before calculations if a patients BMI was <18·5 and >27 kg/m2.
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COPD(33–36). However, in most of these studies, subjects were
stable outpatients. Most of our subjects were hospitalised owing
to an acute exacerbation, and this may have interfered with
their ability or desire to eat. In some patients, inﬂammation is
associated with an increase in REE(37), which, in the presence of
poor dietary intake, may contribute to impaired energy bal-
ance(13). Many studies now show, however, that although
acutely unwell patients have an increase in REE this is more
than compensated for by a decrease in physical activity. As a
result, total daily energy expenditure is unlikely to be more in
sick patients than in healthy individuals(38,39). In a study by
Vermeeren et al.(13), energy intake was 4469 (SD 2293) kJ (1068
(SD 548) kcal) on the 1st day during hospitalisation but increased
substantially to 9050 (SD 2489) kJ (2163 (SD 595) kcal) at day 4.
Although a higher energy intake was seen in a previous study in
Iceland (7615 kJ/d (1820 kcal/d))(16), the median total energy
intake for the 3 d measured in all subjects in our study was 5778
(SD 1598) kJ (1381 (SD 382) kcal). However, in agreement with
the study by Vermeeren et al.(13), total energy and protein
intakes in our study signiﬁcantly increased during hospitalisa-
tion among subjects at nutritional risk (from median 5314 (95 %
CI 4059, 6372) kJ/d (1270 (95 % CI 970, 1523) kcal/d) to 5858
(95 % CI 1117, 7167) kJ/d (1400 (95 % CI 267, 1713) kcal/d) and
54·3 (95 % CI 0·9, 65·6) g protein/d to 59·4 (95 % CI 51·8, 71·3) g
protein/d). The reason for different results might be related to
differences in methodology – for example, the duration and
timing of the dietary record(13) or dietary assessment
method(23). Furthermore, an increased intake during hospitali-
sation might be expected owing to resolution of the disease
exacerbation and nutrition impact symptoms such as dyspnoea
facilitating improved eating and loss of appetite(15).
In our study, the proportion of patients with intake above
75% of their predicted energy and protein requirements did not
differ according to nutritional status. We used the lower limits
(energy 105 kJ/kg per d and protein 1·2 g/kg per d) recom-
mended by Icelandic clinical guidelines(21), but the number of
patients reaching 75% of their energy requirements differed
when using different equations to estimate energy requirement.
Two equations have been developed to predict REE in COPD
patients. In 1988, Moore & Angelillo developed a disease-
speciﬁc formula mainly in men with COPD(40), and in 2010
Nordenson et al. developed a disease-speciﬁc formula in
underweight patients with COPD(41). Using those equations
would have resulted in a different number of patients reaching
the suggested cutoff (≥75%). However, the evidence base for
this cutoff is weak and, to our knowledge, has only been
assessed in a mixed group of hospitalised patients(12,17,18).
There are also some limitations when estimating energy
requirements with the above-mentioned equations – for
example, the equation used in our study and the equation by
Moore & Angelillo(40) only contains body weight. Considering
FFM is a major factor predicting REE in COPD patients(30,42,43),
the prediction of energy requirements using body weight alone
may be inaccurate. In the equation by Nordenson et al.(41), FFM
was used to determine energy requirements; however, their
equation was derived from malnourished but weight-stable
COPD patients and may not therefore be applicable to other
COPD populations – for example weight-losing malnourished
patients or weight-stable adequately nourished patients. Weight
loss is prevalent in patients with COPD and those patients
have higher measured REE compared with those who are
weight stable(30), and thus all those equations might under-
estimate REE.
There was a tendency towards a lower risk of mortality in
those patients who met a higher proportion of their energy
requirements; however, the association did not reach statistical
signiﬁcance. Decreased energy intake is associated with
increased mortality in elderly hospitalised patients, although
few of them had COPD (7%)(9). Furthermore, food intake was
assessed in 16 290 adult hospitalised patients (5·7% with COPD)
on Nutrition Day 2006. Consuming a quarter of the food
provided on Nutrition Day was associated with an increased
risk for dying, with an adjusted hazard ratio of 2·10 (95% CI
1·53, 2·89); when eating nothing 3·02 (95% CI 2·11, 4·32)
compared with those who consumed all the portion (8). The
prevalence of mortality was similar in the present study as in
other studies(5,44). We did not ﬁnd associations with energy and
protein intake and other end points. The lack of signiﬁcant
associations between intake and outcomes in our study might
be related to the very low energy and protein intakes observed,
with thirty-nine (39%) and sixty-three (64%) not achieving
≥ 75% of energy and protein requirement. Higher intakes may
be required to achieve a beneﬁcial effect on LOS and read-
mission rate. In this study, a higher proportion of patients was
re-admitted within 30 d (21%) than has been shown in other
studies(45,46), and it may be that low energy and protein intakes
contributed to the high readmission rate, especially if intakes
did not increase considerably after discharge(12). However, the
lack of associations could also be due to the short period of
time – that is intake only measured for 3 d early in hospital stay.
It has been shown that nutritional supplementation (mainly
using ONS) in COPD outpatients can have a positive impact on
total dietary intake, body weight gain, functional capacity and
quality of life(22,47–49). The timing and type of nutritional inter-
vention during hospitalisation also needs to be studied further
and outcomes relevant to hospital management (e.g. LOS and
readmissions within 30 d) should be included in future studies.
For example, nutritional intervention offered to those at med-
ium nutritional risk before functional decline rather than only
those at high risk and ONS and/or snacks offered rather than
emphasising large meals such as lunch and dinner. Prioritising
patients not reaching their requirement and those who would
beneﬁt from nutritional support might be an appropriate
priority for the dietetic services.
Higher energy and protein intakes were related to higher BMI
and FFMI of our study participants. This is of importance as a
higher BMI and a higher FFMI are related to better survival and
more favourable health outcomes in COPD patients(31,43,50,51).
In a study by Yilmaz et al.(36), similar energy and protein intakes
was observed in patients with low and normal FFMI (7406
(SD 1414) v. 8104 (SD 2535) kJ (1770 (SD 338) v. 1937
(SD 606) kcal), P= 0·478 and 68·4 (SD 15·4) v. 73·7 (SD 26·7) g,
P= 0·946)(36). In contrast, a study by Van de Bool et al.(34)
showed that COPD patients with low FFMI had a higher
energy intake than patients with normal FFMI (9084 (95 % CI
7385, 11494) v. 8297 (95 % CI 6820, 10176) kJ; P= 0·001) and
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the protein intake per kg body weight was higher in subjects
with low FFMI (1·0 g; 95% CI 0·8, 1·3 v. 1·3 g; 95% CI 1·0, 1·8,
P< 0·001). However, higher energy and protein intake in sub-
jects with low FFMI should not be surprising owing to the risk
for increased energy expenditure, and as this group might be
considered at nutritional risk, they are more likely to receive
nutritional therapy in the form of dietary advice and/or ONS(42).
To our knowledge, only one study has previously examined
the correlation between energy and protein intake and disease
severity in patients with COPD(19). Our ﬁndings agree with the
previous study results that showed no correlation between
energy intake and disease severity. However, in their study a
weak correlation was seen between protein intake assessed
with FFQ and certain variables related to lung function (FVC
and VC). No relation was seen with other variables measured
(FEV1 and FEV1/FVC)
(19).
It is a limitation of the present study that it was of observa-
tional design and although we almost reached our calculated
sample of 100, a relatively small sample was in each nutritional
risk subgroup. We recognise that measuring intake for only 3 d
early in hospital stay and not the whole period of hospitalisation
could be a limitation as it is therefore not possible to assess
resolution of intake at hospital discharge. Unfortunately, we did
not assess habitual intake when well, only in the acute state of
hospitalisation. The power calculations were based on difference
in energy intake between groups, but we might have been
underpowered to see signiﬁcant associations with outcomes.
However, this study provides important information about diet-
ary intake early in hospital stay in inpatients with COPD, which
might be used both to guide clinical work and future research.
Conclusions
Energy and protein intake during hospitalisation failed to meet
estimated energy and protein requirements. Despite receiving
similar amounts of food from the hospital, energy and protein
intakes from the two meals (lunch and evening meal) were
lower in malnourished patients than in those who were not at
nutritional risk. However, the contribution of ONS was higher
among malnourished patients, resulting in no difference in daily
total energy and protein intakes between the groups. Hospita-
lisation should be considered a window of opportunity for
detailed nutritional assessment and implementation of long-
term nutritional therapy(52). Further studies are needed on how
to increase energy and protein intake during hospitalisation and
after discharge, and to assess whether higher intakes in relation
to requirements of COPD patients results in better outcomes.
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